Here are seven key notes on major spine and orthopedic device companies.
Titan Spine developed a distribution agreement with Biomet for the Titan Spine Endoskeleton interbody fusion devices to bring them to spine surgeons in Germany.
MAKO Surgical reported a net loss of $21.3 million in the third quarter, nearly four times as much as the $6.6 million loss suffered during the same quarter last year.
Alphatec Spine reported a $14.5 million loss in the third quarter, a 487 percent increase from the $2.5 million loss during the same period last year.
Austin, Texas-based LDR Holding reported a third quarter net loss of nearly $8 million, an increase of 161 percent from 2012's net loss of $3 million.
Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device.
Bacterin International Holdings developed an alliance with DMP Spine Biologics to distribute Bacterin's bone graft products in European markets.
NLT Spine received FDA approval for its second generation PROW FUSION implant and eSPIN discectomy tool for lumbar interbody fusions through a minimally invasive posterior incision.
More Articles on Devices:
Victrex Group Finance Director Steve Barrow to Step Down
Study Shows SpineJack Device Effective for Vertebral Compression Fracture Treatment
NLT Spine Receives FDA Clearance for Second Generation Spine Fusion Devices
MAKO Surgical reported a net loss of $21.3 million in the third quarter, nearly four times as much as the $6.6 million loss suffered during the same quarter last year.
Alphatec Spine reported a $14.5 million loss in the third quarter, a 487 percent increase from the $2.5 million loss during the same period last year.
Austin, Texas-based LDR Holding reported a third quarter net loss of nearly $8 million, an increase of 161 percent from 2012's net loss of $3 million.
Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device.
Bacterin International Holdings developed an alliance with DMP Spine Biologics to distribute Bacterin's bone graft products in European markets.
NLT Spine received FDA approval for its second generation PROW FUSION implant and eSPIN discectomy tool for lumbar interbody fusions through a minimally invasive posterior incision.
More Articles on Devices:
Victrex Group Finance Director Steve Barrow to Step Down
Study Shows SpineJack Device Effective for Vertebral Compression Fracture Treatment
NLT Spine Receives FDA Clearance for Second Generation Spine Fusion Devices